• 2401 West Belvedere Ave.
  • Baltimore, MD 21215

Yoram Unguru

Email: Yunguru@lifebridgehealth.org

Dr. Unguru is a pediatric hematologist/oncologist with joint faculty
appointments at The Herman and Walter Samuelson Children’s Hospital at
Sinai and The Berman Institute of Bioethics, John Hopkins University,
Baltimore, MD where he is a Core Faculty member.  He is also Assistant
Professor in the School of Medicine, Johns Hopkins University. His B.A.
in historical studies and M.A. with a concentration in the history of
medicine and medical ethics were granted at the University of Maryland,
Baltimore County. Dr. Unguru also received a Master of Science
(valedictorian) in interdisciplinary studies in biological and physical
science at Touro College / Barry Z. Levine School of Health Sciences. He
earned his M.D. (valedictorian) at the Technion – Israel Institute of
Technology / Bruce Rappaport Faculty of Medicine. He completed his
pediatric residency at the Children’s Hospital at Sinai and his
pediatric hematology/oncology fellowship at Children’s National
Medical Center in Washington DC.  Dr. Unguru was a postdoctoral
Greenwall Fellow in Bioethics and Public Policy at Johns Hopkins
University.  Dr. Unguru is board certified both in pediatrics and in
pediatric hematology/oncology.

Dr. Unguru’s research interests include the role of children and
providers in facilitating shared decision-making.  His 2007 essay on
this topic, Pediatric Assent: Should Children Decide and Does it Really
Matter? was recognized as the winning bioethics essay by the American
Academy of Pediatrics.  Dr. Unguru’s interests also include research
ethics, end-of-life decision-making, and ethics education.  Dr. Unguru
has served as a consultant to the American Academy of Pediatrics
Committee on Pediatric Research and the American Medical Association
Council on Ethical and Judicial Affairs.  Dr. Unguru is a member of the
Children’s Oncology Group, Bioethics Steering Committee and he
recently completed a term as a member of the American Society of
Clinical Oncology, Ethics Committee.  Dr. Unguru implemented and directs
a clinical ethics curriculum for the pediatric house staff at The Herman
and Walter Samuelson Children’s Hospital at Sinai and is a recipient
of “Teacher of the Year” as chosen by the pediatric house staff at
The Herman and Walter Samuelson Children’s Hospital.  Dr. Unguru is
the Chairman of the Ethics Committee at Sinai Hospital of Baltimore.
Dr. Unguru is currently leading a multidisciplinary, transnational
working group examining the ethical and policy implications of
chemotherapy shortages in childhood cancer.


BA, University of Maryland, Baltimore County
MA, University of Maryland, Baltimore County
MS, Touro College/ Barry Z. Levine School of Health Sciences
MD, Technion- Israel Institute of Technology/ Bruce Rappaport Faculty
of Medicine

Recent Publications:

Unguru Y. Speed and Safety in Drug Approval and Commercialization. Pediatrics. Forthcoming, November 2017.

Barone S, Unguru Y. Should Euthanasia be Considered Iatrogenic? AMA J Ethics. 2017;19(8):802-814.

Unguru Y. Comment on: Contributing Factors and Outcomes of Treatment Refusal in Pediatric Oncology in Germany. Pediatric Blood and Cancer 2017;64(2):395.

Unguru Y, Fernandez CV, Bernhardt B, Berg S, Pyke-Grimm K, Woodman C, Joffe S.  An Ethical Framework for Allocating Scarce Life-saving Chemotherapy and Supportive Care Drugs for Childhood Cancer. JNCI. 2016;108(6):1-7

Unguru YChemotherapy Shortages: When is Enough Enough? Journal of Clinical Pathways. 2016:2(4), 26-29.

Johnson Liza-Marie, Unguru Y.  ­Recruiting Children for Clinical Trials: Lessons from Pediatric Oncology. American Journal of Bioethics. 2015:15(11), 1–3

Unguru Y. Ethical Challenges in Early-Phase Pediatric Research for Life-Limiting IllnessSeminars in Pediatric Neurology. 2015;22(3):177-186.

Simon C, Kodish E, Unguru YCancer, Ethical Issues Related to Diagnosis and Treatment.  Bioethics, 4th Edition.  Edited by Bruce Jennings. Farmington Hills, MI: Macmillan Reference USA, 2014

DeCamp M, Joffe S, Fernandez CV, Faden RR, Unguru Y. Consensus Statement of the Working Group on Chemotherapy Drug Shortages in Pediatric OncologyPediatrics.  2014;133:1-9.

Unguru Y, Joffe Steven, Fernandez Conrad V, Yu A. Ethical Issues for Control arm Patients after Revelation of Benefits of Experimental Therapy. A Framework Modeled in NeuroblastomaJCO. 2013;31(5):641-646.

Unguru Y. Decision-making for Children with Life-limiting Illnesses: A Clinical Approach.  Journal of Health Care Law & Policy. 2012;15(1):117-128.

Unguru Y. Making Sense of Adolescent Decision-making: Challenge and Reality. In: Silber T, English eds. Ethical and Legal Issues in the Care of Adolescents. Adolescent Medicine State of the Art Reviews. 2011;22(2):195-206.

Unguru Y. The Successful Integration of Research and Care: How Pediatric Oncology Became the Subspecialty in which research Defines the Standard of CarePediatric Blood and Cancer 2011;56:1019-1025.

Unguru Y., Sill A, Kamani N.  The Experiences of Children Enrolled in Pediatric Oncology Research: Implications for AssentPediatrics 2010;125:e876-e883.

Unguru Y., Coppes MJ, Kamani N. Rethinking Pediatric Assent: From Requirement to Ideal. Pediatric Clinics of North America 2008;55(1):215-226.

Unguru Y.  Children’s Views on their Involvement in Clinical Research.  A Comment.  Pediatric Blood and Cancer 2008:51(5):716-717.